Resolution of RHCE Haplotype Ambiguities in Transfusion Settings
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115868 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Caroline Izard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Etablissement Français du Sang PACA Corse, 13005 Marseille, France. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Haplotypes, Alleles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by ART ASSOCIATION RECHERCHE EN TRANSFUSION, ART ASSOCIATION RECHERCHE EN TRANSFUSION.
Abstract (Originalsprache)
Red blood cell (RBC) transfusion, limited by patient alloimmunization, demands accurate blood group typing. The Rh system requires specific attention due to the limitations of serological phenotyping methods. Although these have been compensated for by molecular biology solutions, some RhCE ambiguities remain unresolved. The RHCE mRNA length is compatible with full-length analysis and haplotype discrimination, but the RHCE mRNA analyses reported so far are based on reticulocyte isolation and molecular biology protocols that are fastidious to implement in a routine context. We aim to present the most efficient reticulocyte isolation method, combined with an RT-PCR sequencing protocol that embraces the phasing of all haplotype configurations and identification of any allele. Two protocols were tested for reticulocyte isolation based either on their size/density properties or on their specific antigenicity. We show that the reticulocyte sorting method by antigen specificity from EDTA blood samples collected up to 48 h before processing is the most efficient and that the combination of an RHCE-specific RT-PCR followed by RHCE allele-specific sequencing enables analysis of cDNA RHCE haplotypes. All samples analyzed show full concordance between RHCE phenotype and haplotype sequencing. Two samples from the immunohematology laboratory with ambiguous results were successfully analyzed and resolved, one of them displaying a novel RHCE allele (RHCE*03 c.340C>T).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Etablissement Français du Sang PACA Corse, 13005 Marseille, France.
- Aix Marseille University CNRS EFS ADES UMR7268, 13015 Marseille, France.
ORCID-Profile: Julie Di Cristofaro
Förderung
- This research was funded by ART ASSOCIATION RECHERCHE EN TRANSFUSION
- ART ASSOCIATION RECHERCHE EN TRANSFUSION
Zitieren
APA
Izard, C., Laget, L., Beley, S., Bichel, N., De Boisgrollier, L., Picard, C., Chiaroni, J., & Di Cristofaro, J. (2024). Resolution of RHCE Haplotype Ambiguities in Transfusion Settings. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115868
Vancouver
Izard C, Laget L, Beley S, Bichel N, De Boisgrollier L, Picard C, et al. Resolution of RHCE Haplotype Ambiguities in Transfusion Settings. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115868
BibTeX
@article{Izard2024,
author = {Izard, Caroline and Laget, Laurine and Beley, Sophie and Bichel, Nelly and De Boisgrollier, Lugdivine and Picard, Christophe and Chiaroni, Jacques and Di Cristofaro, Julie},
title = {Resolution of RHCE Haplotype Ambiguities in Transfusion Settings},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115868}
}
EUVIMED